Navigation Links
Medifast Weight Control Centers to Open in California
Date:6/3/2008

OWINGS MILLS, Md., June 3 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) today announced that Medifast Franchise Systems has sold the rights to open four Medifast Weight Control Centers in Southern California and three Medifast Weight Control Centers in Central California to two different local business operators.

The entire build-out process will take no more than two years to complete. The Southern California franchisee also has the right to open four additional Medifast Weight Control Centers in San Diego County over the next two years, bringing the total to eight locations. The Central California franchisee plans to open Centers in Modesto, Stockton, and Pleasanton over the next 18 months.

"The sale of nine new Medifast Weight Control Center franchises in California is a significant step toward growing a successful franchise network of Medifast Weight Control Centers," said Michael S. McDevitt, Chief Executive Officer, Medifast, Inc.

In December 2007, Medifast Franchise Systems received approval to sell franchises and has sold a total of 13 locations.

Medifast Weight Control Centers offers guaranteed results on a supervised program. Each client receives a customized solution to their weight-loss needs, and can expect to lose an average of two to five pounds per week. Behavior modification tools to help individuals change their overall lifestyles are also part of the program.

The Company currently operates 14 corporate-owned Medifast Weight Control Centers in Texas and Florida, and will open six more Centers in Houston and two more Centers in Dallas by August 2008. The Company plans to open an additional 20 corporate-owned Centers over the next two years in selected markets.

For more information on this business opportunity, please visit http://www.MedifastCenters.com.

Franchisee Requests:

Rick Logsdail

Vice President of Sales

Medifast Franchise Systems

410-504-8180

RLogsdail@ChooseMedifast.com

MED-G

About Medifast:

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by 15,000 physicians and used by over one million customers. Medifast programs have been proven effective through studies by major university teaching hospitals. Medifast was founded in 1980 and is located in Owings Mills, Maryland.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Medifast's inability to attract and retain independent Associates and Members, stability in the pricing of print, TV and Direct Mail marketing initiatives affecting the cost to acquire customers, increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and new channels of distribution. Although Medifast's believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.


'/>"/>
SOURCE Medifast, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medifast Announces Winners of Mother-Daughter Challenge
2. Medifast, Inc. Announces Support for Microsoft HealthVault
3. Medifast Announces Updated Full Year 2007 Guidance
4. Medifast Announces Third-Quarter 2007 Results
5. Medifast, Inc. Receives Approval to Sell Medifast Weight Control Centers Franchises in Seven Additional States
6. Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008
7. Medifast, Inc. Director of Research & Development Co-Authors Health Book
8. Medifast Receives Notice Regarding NYSE Listing
9. Medifast Offers Stranded Pure Weight Loss Clients Unique Options
10. Medifast Offers 5 Heart Healthy Tips in Recognition of Fridays National Wear Red Day
11. Medifast Franchise Systems Sells First Territory in Baltimore
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live ... recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken by ...
(Date:12/7/2016)... Scottsdale, AZ (PRWEB) , ... ... ... pioneer, ElectroMedical Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus ... , WellnessPro Plus substantially enhances the WellnessPro platform by expanding the treatment ...
(Date:12/7/2016)... ... 2016 , ... “Walking With God: Inspirational Lessons from My Life's Journey”: ... be aware of God's direction in their lives. “Walking With God: Inspirational Lessons from ... active church leader. , Sanford says, “I enjoy sharing the true stories ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg Leyer, the ... Probiotic Association’s Washington DC workshop on November 2nd. The conference was an opportunity ... probiotic dietary supplement regulations. , Dr. Leyer spoke about two main topics ...
(Date:12/6/2016)... ... 2016 , ... The International Vaccine Institute (IVI) and GeneOne ... Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The collaboration will accelerate MERS-CoV vaccine development ... in the event of a future outbreak. , IVI and GeneOne held a ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... the ralinepag phase 2 trial.  Ralinepag is an oral, ... the treatment of pulmonary arterial hypertension (PAH). The study ... "This marks an important step in the development of ... our pipeline," said Amit Munshi , Arena,s President ...
(Date:12/7/2016)... , Dec. 7, 2016   TraceLink Inc ... for connecting the Life Sciences supply chain and ... today announced that Tjoapack has selected TraceLink,s serialization ... customers comply with the rapidly approaching serialization deadlines ... (DSCSA) in 2017 and the EU Falsified Medicines ...
(Date:12/7/2016)... ZIONA SCIENCE PARK , ... biotechnology company Kadimastem (TASE: KDST) announced today the signing of a ... collaboration between the companies. The synergy between the companies will assist ... collaboration as a worldwide leader in innovative treatment for severe diseases ... ...
Breaking Medicine Technology: